A randomised controlled trial investigating ventilation imaging to improve the quality of life for patients with lung cancer treated with radiation therapy VITaL

This trial is testing a new treatment planning method for patients with lung cancer who will be treated with radiation therapy. This new method is called Computed Tomography (CT) ventilation imaging. It aims to help protect the healthiest parts of patient's lungs from being injured by the radiation therapy. The investigators will determine whether healthy lung sparing can improve the quality of life in these patients.
For more information about the VITaL trial, go to:
https://https://image-x.sydney.edu.au/the-vital-clinical-trial/

Primary Sponsor

The University of Sydney

Collaborating Groups

Trans Tasman Radiation Oncology Group (TROG)

Accrual Target

165

Trial Chairperson

Prof Paul Keall - Image X Institute

Trial Contact

qa@trog.com.au

Clinical Trial Registration

Related Post

14 April, 2026

Consumer Engagement Charter cements TROG’s commitment to listen to consumer voices

LATEST NEWS: 14 April 2026 TROG has made a

9 April, 2026

Vale Professor Jim Denham OAM, TROG founder and world-class researcher

9 April 2026 TROG Cancer Research honours the life